Divi's Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Divi's Laboratories Ltd. on BSE

Load latest

Divi's Laboratories Ltd.

20 May 2011

6544.50

-1.27%

Company Update

Results Press Release

BSE India

Divis Laboratories Ltd has informed BSE regarding a Press Release dated May 20, 2011 titled "Divis Labs PAT for Q4 grew by 36% to Rs.175 crores".

pdf

Divi's Laboratories Ltd.

20 May 2011

6544.50

-1.27%

Corp. Action

Board recommends Dividend

BSE India

Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2011, inter alia, has recommended a dividend of 500% i.e. Rs. 10/- per equity share of Rs. 2/- face value for the year ended March 31, 2011.

Divi's Laboratories Ltd.

20 May 2011

6544.50

-1.27%

Board Meeting

Announces Q4 & FY 11 Results

BSE India

Divis Laboratories Ltd has informed BSE that has announced the following results for the quarter & year ended March 31, 2011:The Audited results for the Quarter ended March 31, 2011 The Company has posted a net profit of Rs 1747.50 million for the quarter ended March 31, 2011 as compared to Rs 1300.10 million for the quarter ended March 31, 2010. Total Income has increased from Rs 3156.70 million for the quarter ended March 31, 2010...

pdf

Divi's Laboratories Ltd.

06 May 2011, 10:34AM

6544.50

-1.27%

Board Meeting

FY 11 results on May 20, 2011

BSE India

Divis Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 20, 2011, inter alia, to consider and approve the audited financial results for the year ended March 31, 2011 and to recommend Dividend on Equity Shares for the year ended 31, 2011, if any.

Divi's Laboratories Ltd.

25 Apr 2011

6544.50

-1.27%

Result

Publish Audited Results

BSE India

Divis Laboratories Ltd has informed BSE that the Audited Financial Results of the Company for the entire financial year 2010-2011 shall be considered and published by the Company within the stipulated time period of sixty days from the end of the financial year i.e., on or before May 30, 2011.Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on March 31, 2011.

Divi's Laboratories Ltd.

04 Apr 2011

6544.50

-1.27%

Corp. Note

Clarifies on news item

BSE India

With reference to the news item appearing in a leading news channel on April 01, 2011 titled "Divi's Labs is looking to acquire US Biotech companies", Divis Laboratories Ltd has clarified to BSE that there are no plans or discussions or negotiations to acquire any biotech Company or of any fund raising.

Divi's Laboratories Ltd.

03 Mar 2011

6544.50

-1.27%

Corp. Note

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

BSE India

Divis Laboratories Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:

pdf

Divi's Laboratories Ltd.

04 Feb 2011

6544.50

-1.27%

Corp. Note

Outcome of Committee Meeting

BSE India

Divis Laboratories Ltd has informed BSE that Compensation Committee of Board of Directors at its meeting held on February 04, 2011 made the allotment of 29690 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132595110 equity shares from 132565420 equity shares of face value Rs. 2/- each.

Divi's Laboratories Ltd.

04 Feb 2011

6544.50

-1.27%

Corp. Note

Results Press Release

BSE India

Divis Laboratories Ltd has informed BSE regarding a Press Release dated February 04, 2011 titled "Divi's Labs earns an Income of Rs. 313 crores for Q3 of FY11"

pdf

Divi's Laboratories Ltd.

04 Feb 2011

6544.50

-1.27%

Corp. Note

Announces Q3 results

BSE India

Divis Laboratories Ltd has announced the following Unaudited results for the quarter ended December 31, 2010:The Company has posted a net profit of Rs 1015.70 million for the quarter ended December 31, 2010 as compared to Rs 687.90 million for the quarter ended December 31, 2009. Total Income has increased from Rs 1996.40 million for the quarter ended December 31, 2009 to Rs 3209.80 million for the quarter ended December 31, 2010....

pdf

Is Divi's Laboratories Ltd. worth buying?

748 Votes:

Buy 78.07%

Sell 14.97%

Hold 6.95%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf

Near 52W High of ₹6764.00

Divi's Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Divi's Laboratories Ltd. on BSE